EN CN


In Vitro Safety Assessment

Return

Metabolic and Gastrointestinal Ion Channel Portfolio

Metabolic and Gastrointestinal Ion Channels

Target Biology

Ion channels play important roles in hormone secretion, gut motility, pain signaling, inflammation, and electrolyte balance. The following targets are relevant to metabolic and gastrointestinal research.

01 · Kv1.3

A voltage-gated potassium channel involved in T-cell activation and insulin secretion, making it a potential target for metabolic disorders including diabetes and obesity.

02 · Kir6.2/SUR1

An ATP-sensitive potassium channel essential for pancreatic β-cell insulin secretion and a relevant target for diabetes research.

03 · CFTR

The Cystic Fibrosis Transmembrane Conductance Regulator controls chloride transport and electrolyte balance, with therapeutic relevance to diarrheal disease and other electrolyte disorders.

04 · TRPV1

A transient receptor potential channel involved in pain perception and inflammation, with relevance to inflammatory bowel disease and other gastrointestinal inflammatory conditions.

05 · P2X3

A purinergic receptor involved in sensory signaling related to pain and inflammation, with potential relevance to irritable bowel syndrome and inflammatory pain disorders.

06 · 5-HT3A

An ionotropic serotonin receptor that modulates gut motility and secretion and is relevant to gastrointestinal disorders including irritable bowel syndrome, nausea, and vomiting.

PORTFOLIO SCOPE

Metabolic and gastrointestinal profiling

Our metabolic and gastrointestinal portfolio provides an off-target profile of principal ion channels that influence the physiological functions of metabolic and gastrointestinal systems.

The portfolio focuses on channels linked to hormone secretion, gut motility, and electrolyte balance. It supports the identification of selective targets for therapeutic research in metabolic disorders such as diabetes and obesity, as well as gastrointestinal diseases including diarrhea, irritable bowel syndrome, and inflammatory bowel disease.

TARGET COVERAGE

Ion-channel assay panel

Ion Channel FamilyTargetMethodSpeciesMode
Chloride channelCFTRManual patch clamphumanAgonist or Antagonist
ANO1Manual patch clamphumanAgonist or Antagonist
Voltage-gated potassium channelKv1.3Manual patch clamphumanAgonist or Antagonist
KCNQ5Manual patch clamphumanAgonist or Antagonist
Potassium channel, inward rectifierKir6.2/Sur1Manual patch clamphumanAgonist or Antagonist
Voltage-gated calcium channelCav1.2Manual patch clamphumanAgonist or Antagonist
Hyperpolarization-activated channelHCN2Manual patch clamphumanAgonist or Antagonist
HCN4Manual patch clamphumanAgonist or Antagonist
Potassium channel, calcium activatedBKManual patch clamphumanAgonist or Antagonist
IKManual patch clamphumanAgonist or Antagonist
SK2Manual patch clamphumanAgonist or Antagonist
SK3Manual patch clamphumanAgonist or Antagonist
Ligand-gated ion channel5-HT3AManual patch clamphumanAgonist or Antagonist
TRPV1Manual patch clamphumanAgonist or Antagonist
P2X3Manual patch clamphumanAgonist or Antagonist
nAChR α7/RIC3Manual patch clamphumanAgonist or Antagonist

Contact Us

We value your inquiries and are here to provide you with tailored solutions for your drug discovery and development needs. Whether you have questions, require more information, or are interested in discussing potential collaborations, our team of experts is just a message away.
Feel free to reach out to us.

We are a CRO service organization, not a hospital




Get a quote

Go top